Key result
Lipophilic HMG-CoA reductase inhibitors significantly worsened myocardial segment function and reduced ATP levels after ischemia and reperfusion compared to vehicle.
Why the study?
Does pretreatment with lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs subjected to ischemia and reperfusion?
Does pretreatment with lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs subjected to ischemia and reperfusion?
Lipophilic statins may exacerbate myocardial stunning and deplete ATP during ischemia-reperfusion in a canine model.
No takes yet. Share an insight, caveat, or question.
May worsen postischemic stunning in canine models; leaves open human relevance and requires clinical validation.
Satoh et al. (2000) studied Myocardial stunning. Lipophilic HMG-CoA reductase inhibitors (atorvastatin, fluvastatin, cerivastatin) vs. Vehicle was evaluated on Myocardial segment function and tissue levels of ATP. Lipophilic HMG-CoA reductase inhibitors significantly worsened myocardial segment function and reduced ATP levels after ischemia and reperfusion compared to vehicle.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: